No Data
No Data
Dong-E-E-Jiao Forecasts Up to 43% Rise in H1 Profit
Dong-E-E-Jiao (SHE:000423) forecasts its attributable net profit will rise 31% to 43% to between 695 million yuan and 760 million yuan in the first half from 531.1 million yuan in the year-ago period.
Chinare Pharma (03320.HK): Dong-E-E-Jiao's net income for the first half of the year is expected to increase by 31% to 43% year-on-year.
On July 12th, Guolonghui reported that Chinares Pharma (03320.HK) released an announcement that on July 11, 2024, Dong-E-E-Jiao (000423.SZ) announced its performance forecast for the half year ended June 30, 2024. Accordingly, its net income attributed to Dong-E-E-Jiao's shareholders for the six months ended June 30, 2024 is expected to be approximately RMB 695 million to RMB 760 million, an increase of about 31% to 43% compared to the same period last year of about RMB 531.1136 million after deducting non-recurring gains and losses, and the net income is expected to be approximately RMB 658 million.
Dong-E-E-Jiao: 2024 Interim Performance Forecast
Dong-e-e-jiao (000423.SZ) announced a profit increase, with a net income expected to be between 0.695 billion yuan and 0.76 billion yuan in the first half of the year, an increase of 31%-43% compared to the same period last year.
Dong-E-E-Jiao (000423.SZ) released its 2024 interim performance forecast, expecting a net profit attributable to shareholders of listed companies of... in the first half of the year.
As of July 10th, 2024, Dong-E-E-Jiao (000423.SZ) has a total of 44,961 shareholders.
On July 11th, Gelunhui reported that as of July 10, 2024, the total number of shareholders of Dong-E-E-Jiao (000423.SZ) was 44,961 on the investor interaction platform.
Dong-e-e-jiao (000423.SZ) plans to publicly list and transfer some of its property.
Dong-E-E-Jiao (000423.SZ) announced that the company intends to sell its properties through a qualified property trading platform...
No Data